![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 16, 2018 1:12:10 PM
I just wonder if IPIX's drugs are caught in Phase 2 drug purgatory, i.e. the cost of a Phase 3 drug trial is greater than the potential drug profits, given the limited time left on their drug patents. I've read there are many promising drugs in this state. A change in the patent law to allow exclusive sales for a minimum time, even if the patent has expired, is being proposed. But don't hold your breath.
As for the supposed term sheet, and potential partner, it seems any potential partner has IPIX over the barrel. The longer they wait, the cheaper the company becomes. They are certainly waiting.
I hope no one seriously hurt their finances on this stock. It was a good fling. It seemed that IPIX had some very promising drugs. But alas that appears to be up in smoke. I've walked away with a loss that stings, but fortunately nothing that has significantly hurt me.
Finally, I hope all those who touted this stock over the years seriously consider the consequences of their actions, and why their recommendations turned out so tragically wrong.
Regards,
Michael
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM